Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYOV and other ETFs, options, and stocks.
Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on the development and commercialization of therapies for the treatment of women's health and endocrine diseases.
David C. Marek
London, Greater London
52 Week High
52 Week Low
Recap: Myovant Sciences Q1 Earnings
Shares of Myovant Sciences (NYSE:MYOV) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 8
-$0.33 per share
-$0.67 per share